Select for export A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811261424214 PubMed 41825921 Copy citation Copy BibTeX Journal of Psychopharmacology 2026-03-12 Francisco A. Moreno, Katja Ehrmann Allen, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze OpenAlex Published psilocybin AnxietyOCDChronic Pain Randomized Controlled Trial More
Select for export Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.schres.2026.03.003 PubMed 41830808 Copy citation Copy BibTeX Schizophrenia Research 2026-03-12 Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad OpenAlex Published psilocybin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin Trends in States That Decriminalized Use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jama.2026.1952 PubMed 41817506 Copy citation Copy BibTeX JAMA 2026-03-11 Joshua C. Black, Gabrielle E. Bau, Ryan R. Cook, Elizabeth A. Bemis, Andrew A. Monte OpenAlex Published psilocybin Observational StudyToxicity Observational Study More
Select for export Discovery of the closest free-living relative of the domesticated ‘magic mushroom’ Psilocybe cubensis in Africa Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1098/rspb.2025.2270 PubMed 41818815 Copy citation Copy BibTeX Proceedings of the Royal Society B Biological Sciences 2026-03-10 Alexander J. Bradshaw, Cathy Sharp, B. van der Merwe, Keaton Tremble, Bryn T. M. Dentinger OpenAlex Published psilocybin General Other More
Select for export Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/0118715273434237251212095005 PubMed 41833044 Copy citation Copy BibTeX CNS & Neurological Disorders - Drug Targets 2026-03-10 Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh OpenAlex Published psilocybin DepressionPTSDAddiction Other More
Select for export Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jddst.2026.108228 Copy citation Copy BibTeX Journal of Drug Delivery Science and Technology 2026-03-09 Vorawut Wongumpornpinit, K Ingkaninan, Prapapan Temkitthawon, Neti Waranuch, Rhannanda Copetti Pivetta, Jieyu Zuo OpenAlex Published psilocybin Clinical Trial Clinical Trial More
Select for export Psilocybin or Nicotine Patch for Smoking Cessation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2026.0972 PubMed 41805956 Copy citation Copy BibTeX JAMA Network Open 2026-03-09 MW Johnson, Gideon P. Naudé, Peter S. Hendricks, Albert Garcia-Romeu OpenAlex Published psilocybin AddictionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin microdosing in the United States: Insights from a nationally representative survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.70368 PubMed 41795902 Copy citation Copy BibTeX Addiction 2026-03-07 Michelle Priest, Beau Kilmer, Rajeev Ramchand, Samer Atshan OpenAlex Published psilocybin AddictionChronic PainMicrodosing Observational Study More
Select for export Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ajhp/zxag062 PubMed 41784123 Copy citation Copy BibTeX American Journal of Health-System Pharmacy 2026-03-03 Jennifer E. Thomas, Anna Dellarole, Joshua Caballero OpenAlex Published psilocybin AnxietyPTSDPharmacology Randomized Controlled Trial More
Select for export Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsptsci.5c00484 PubMed 41852641 Copy citation Copy BibTeX ACS Pharmacology & Translational Science 2026-03-02 Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt OpenAlex Published psilocybin DepressionAnxietyPharmacology Randomized Controlled Trial More
Select for export Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.5c00879 PubMed 41773421 Copy citation Copy BibTeX ACS Chemical Neuroscience 2026-03-02 Samuel E. Williamson, Elise K. Burkhartzmeyer, Michael T. Faley, Rachel Friedman Ohana, Ilia A. Guzei, Mike Valley OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Public attitudes diverge sharply on legal use of psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/mhw.34775 Copy citation Copy BibTeX Mental Health Weekly 2026-03-01 Valerie A. Canady OpenAlex Published psilocybin AddictionConsciousnessToxicity Other More
Select for export Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5281/zenodo.18825289 Copy citation Copy BibTeX Zenodo (CERN European Organization for Nuclear Research) 2026-02-28 Stanley Kisourin OpenAlex Published psilocin PharmacologyMechanism of ActionReceptor Pharmacology Other More
Select for export A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20451253261433836 PubMed 41918771 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2026-02-28 Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5281/zenodo.18796594 Copy citation Copy BibTeX Zenodo (CERN European Organization for Nuclear Research) 2026-02-28 Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian OpenAlex Published psilocybin DepressionPharmacologyAnimal Study Animal Study More
Select for export Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain No abstract availability was recorded for this entry. Details DOI 10.1016/j.jpain.2025.105705 Copy citation Copy BibTeX Journal of Pain 2026-02-28 Greg Corder, Sophie Rogers, Corinna Oswell OpenAlex Published psilocybin Chronic PainMechanism of Action Other More
Select for export Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/14767503251404263 Copy citation Copy BibTeX Action Research 2026-02-28 David Wrathall, Hannah Gosnell, Fern Wickson, Erika Spanger, Associates* OpenAlex Published psilocybin AnxietyMechanism of ActionConsciousness Other More
Select for export Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/adb.70111 PubMed 41780506 Copy citation Copy BibTeX Addiction Biology 2026-02-28 Isis Koutrouli, Vojtěch Brejtr, Marek Schwendt, Kacper Witek, Chrysostomos Charalambous, K. Aleksič OpenAlex Published psilocybin AnxietyAddictionPharmacology Clinical Trial More
Select for export Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2025-107512 PubMed 41819589 Copy citation Copy BibTeX BMJ Open 2026-02-28 Rosalind McAlpine, Magdalena Jaglinska, Krisztina Jedlovszky, Joanna Kuc, Ariel Castro, Alexandre Piot OpenAlex Published psilocybin AnxietyChronic PainBrain Imaging Randomized Controlled Trial More
Select for export Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.vhri.2026.101605 PubMed 41842876 Copy citation Copy BibTeX Value in Health Regional Issues 2026-02-28 Yosr Ziadi, Taehwan Park OpenAlex Published psilocybin DepressionChronic PainRandomized Controlled Trial Randomized Controlled Trial More
